An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 204-213

  von Elverfeldt, Dominik ^a   Meißner, Mirko ^a   Peter, Karlheinz ^b   Paul, Dominik ^a   Meixner, Fabian ^a   Neudorfer, Irene ^a   Merkle, Annette ^a   Harloff, Andreas ^a   Zirlik, Andreas ^a   Schöllhorn, Joachim ^a   Markl, Michael ^a   Hennig, Jürgen ^a   Bode, Christoph ^a   von zur Muhlen, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Carotid endarterectomy; Magnetic resonance imaging; Platelets

Indexed keywords

CONTRAST MEDIUM; FIBRINOGEN RECEPTOR; IRON OXIDE;

AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING SITE; CLINICAL ARTICLE; ENDARTERECTOMY; FEMALE; FLOW KINETICS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK;

AGED; BINDING SITES; CAROTID STENOSIS; CONTRAST MEDIA; ENDARTERECTOMY, CAROTID; FEMALE; FERRIC COMPOUNDS; HUMANS; LIGANDS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; MOLECULAR IMAGING; PLATELET ACTIVATION; RHEOLOGY;

EID: 84858713987     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.482     Document Type: Article

References (26)

1. Gawaz M, Stellos K, Langer HF. Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost 2008; 6(2): 235-242.
2. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115(12): 3378-3384.
3. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004; 3(11): 913-925.
4. Choudhury RP, Fisher EA. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol 2009; 29(7): 983-991.
5. Chen DL, Kinahan PE. Multimodality molecular imaging of the lung. J Magn Reson Imaging 2010; 32(6): 1409-1420.
6. Bonnet CS, Tóth E. Smart MR imaging agents relevant to potential neurologic applications. AJNR Am J Neuroradiol 2010; 31(3): 401-409.
7. Bogdanov A, Mazzanti ML. Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol 2011; 38(1): 42-54.
8. von Zur Muhlen C, Sibson NR, Peter K, Campbell SJ, Wilainam P, Grau GE, Bode C, Choudhury RP, Anthony DC. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 2008; 118(3): 1198-1207.
9. von Zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008; 118(3): 258-267.
10. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 2005; 53(2): 329-338.
11. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006; 55(2): 242-249.
12. Spuentrup E, Katoh M, Wiethoff AJ, Parsons EC Jr, Botnar RM, Mahnken AH, Gunther RW, Buecker A. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Am J Respir Crit Care Med 2005; 172(4): 494-500.
13. Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC Jr, Botnar RM, Weisskoff RM, Graham PB, Manning WJ, Gunther RW. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005; 111(11): 1377-1382.
14. Schwarz M, Katagiri Y, Kotani M, Bassler N, Loeffler C, Bode C, Peter K. Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (αIIbβ3, CD41/CD61). J Pharmacol Exp Ther 2004; 308(3): 1002-1011.
15. Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation. Arterioscler Thromb Vasc Biol 2007; 27(5): 1206-1212.
16. Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circul Res 2006; 99(1): 25-33.
17. Schwarz M, Rottgen P, Takada Y, Le Gall F, Knackmuss S, Bassler N, Buttner C, Little M, Bode C, Peter K. Single-chain antibodies for the conformation-specific blockade of activated platelet integrin αIIbβ3 designed by subtractive selection from naive human phage libraries. FASEB J 2004; 18(14): 1704-1706.
18. von zur Mühlen C, Peter K, Ali Z, Schneider J, McAteer MA, Channon KM, Bode C, Choudhury RP. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res 2009; 46(1): 6-14.
19. Rothwell PM, Gutnikov SA, Warlow CP. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 2003; 34(2): 514-523.
20. Vanninen RL, Manninen HI, Partanen PL, Vainio PA, Soimakallio S. Carotid artery stenosis: clinical efficacy of MR phase-contrast flow quantification as an adjunct to MR angiography. Radiology 1995; 194(2): 459-467.
21. Burrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb 1991; 11(6): 1678-1689.
22. Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, Sabetai M, Thomas DJ, Tegos T, Geroulakos G, Labropoulos N, Doré CJ, Morris TP, Naylor R, Abbott AL. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010; 52: 1486-1496.
23. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 2004; 101(30): 10901-10906.
24. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New Engl J Med 2005; 352(16): 1685-1695.
25. Slager CJ, Wentzel JJ, Gijsen FJ, Thury A, van der Wal AC, Schaar JA, Serruys PW. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2005; 2(9): 456-464.
26. von zur Muhlen C, von Elverfeldt D, Choudhury R, Ender J, Ahrens I, Schwarz M, Hennig J, Bode C, Peter K. A functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths. Mol Imag 2008; 7(2): 59-67.